Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer

BACKGROUND: Mutations in the KRAS gene can be detected in about 70–90% of pancreatic cancer (PC) cases. Whether these mutations have a prognostic or predictive value remains elusive. Furthermore, the clinical relevance of the extended RAS (KRAS+NRAS) mutational status is unclear in PC. METHODS: We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Michael, Ormanns, Steffen, Baechmann, Sibylle, Remold, Anna, Kruger, Stephan, Westphalen, Christoph B, Siveke, Jens T, Wenzel, Patrick, Schlitter, Anna Melissa, Esposito, Irene, Quietzsch, Detlef, Clemens, Michael R, Kettner, Erika, Laubender, Ruediger P, Jung, Andreas, Kirchner, Thomas, Boeck, Stefan, Heinemann, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Genetics & Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520094/
https://www.ncbi.nlm.nih.gov/pubmed/28449008
http://dx.doi.org/10.1038/bjc.2017.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520094/
https://www.ncbi.nlm.nih.gov/pubmed/28449008
http://dx.doi.org/10.1038/bjc.2017.115

Ejemplares similares